Thursday, June 2, 2016

Oncogene - Table of Contents alert Volume 35 Issue 22

If you are unable to see the message below, click here to view.
Oncogene

Advertisement
Oncogenesis Focus Collection: Cancer & Metabolism

While extremely diverse in origin, all cancer cells show profound metabolic changes. The articles in this Special Issue discuss the connection between cancer cells and their metabolic adaptations, from molecular mechanisms to anticancer therapies, and highlight the dialogue between whole organism and cancer cells.

Explore the complete Special Issue in full.

TABLE OF CONTENTS

Volume 35, Issue 22 (June 2016)

In this issue
Original Articles
Corrigenda

Also new
AOP
Advertisement

Immune Profiling in Health and Disease

Presented by: Adaptive Biotechnologies | Nature Immunology | Nature Medicine | Nature Biotechnology | Nature Genetics

October 3-5, 2016 | Bell Harbor International Conference Center, Seattle, WA, USA
Register now!

Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
View most cited articles — which ones have you missed?

Take a look at what your colleagues have been citing across the Oncogene journal over the past two years.

Click here to visit special webpage
 

Original Articles

Top

Cyclin D1 promotes BRCA2-Rad51 interaction by restricting cyclin A/B-dependent BRCA2 phosphorylation

C Chalermrujinanant, W Michowski, G Sittithumcharee, F Esashi and S Jirawatnotai

Oncogene 2016 35: 2815-2823; advance online publication, September 21, 2015; 10.1038/onc.2015.354

Abstract | Full Text

SLUG is required for SOX9 stabilization and functions to promote cancer stem cells and metastasis in human lung carcinoma

S Luanpitpong, J Li, A Manke, K Brundage, E Ellis, S L McLaughlin, P Angsutararux, N Chanthra, M Voronkova, Y C Chen, L Wang, P Chanvorachote, M Pei, S Issaragrisil and Y Rojanasakul

Oncogene 2016 35: 2824-2833; advance online publication, September 21, 2015; 10.1038/onc.2015.351

Abstract | Full Text

JRK is a positive regulator of β-catenin transcriptional activity commonly overexpressed in colon, breast and ovarian cancer

L Pangon, I Ng, M Giry-Laterriere, N Currey, A Morgan, F Benthani, P N Tran, S Al-Sohaily, E Segelov, B L Parker, M J Cowley, D C Wright, L St Heaps, L Carey, I Rooman and M R J Kohonen-Corish

Oncogene 2016 35: 2834-2841; advance online publication, October 12, 2015; 10.1038/onc.2015.347

Abstract | Full Text

The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development

A-L Joly, A Deepti, A Seignez, A Goloudina, S Hebrard, E Schmitt, S Richaud, E Fourmaux, A Hammann, A Collura, M Svrcek, G Jego, E Robinet, E Solary, O Demidov, E Kohli and C Garrido

Oncogene 2016 35: 2842-2851; advance online publication, September 14, 2015; 10.1038/onc.2015.242

Abstract | Full Text

Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1

D Weekes, T G Kashima, C Zandueta, N Perurena, D P Thomas, A Sunters, C Vuillier, A Bozec, E El-Emir, I Miletich, A Patiño-Garcia, F Lecanda and A E Grigoriadis

Oncogene 2016 35: 2852-2861; advance online publication, September 21, 2015; 10.1038/onc.2015.344

Abstract | Full Text

NFATc2 is an intrinsic regulator of melanoma dedifferentiation

V Perotti, P Baldassari, A Molla, C Vegetti, I Bersani, A Maurichi, M Santinami, A Anichini and R Mortarini

Oncogene 2016 35: 2862-2872; advance online publication, September 21, 2015; 10.1038/onc.2015.355

Abstract | Full Text

Conjugation of SUMO to p85 leads to a novel mechanism of PI3K regulation

C F de la Cruz-Herrera, M Baz-Martínez, V Lang, A El Motiam, J Barbazán, R Couceiro, M Abal, A Vidal, M Esteban, C Muñoz-Fontela, A Nieto, M S Rodríguez, M Collado and C Rivas

Oncogene 2016 35: 2873-2880; advance online publication, September 28, 2015; 10.1038/onc.2015.356

Abstract | Full Text

Estrogen promotes the brain metastatic colonization of triple negative breast cancer cells via an astrocyte-mediated paracrine mechanism

C A Sartorius, C T Hanna, B Gril, H Cruz, N J Serkova, K M Huber, P Kabos, T B Schedin, V F Borges, P S Steeg and D M Cittelly

Oncogene 2016 35: 2881-2892; advance online publication, September 28, 2015; 10.1038/onc.2015.353

Abstract | Full Text

CPEB1 mediates epithelial-to-mesenchyme transition and breast cancer metastasis

K Nagaoka, K Fujii, H Zhang, K Usuda, G Watanabe, M Ivshina and J D Richter

Oncogene 2016 35: 2893-2901; advance online publication, September 28, 2015; 10.1038/onc.2015.350

Abstract | Full Text

USP4 inhibits p53 and NF-κB through deubiquitinating and stabilizing HDAC2 OPEN

Z Li, Q Hao, J Luo, J Xiong, S Zhang, T Wang, L Bai, W Wang, M Chen, W Wang, L Gu, K Lv and J Chen

Oncogene 2016 35: 2902-2912; advance online publication, September 28, 2015; 10.1038/onc.2015.349

Abstract | Full Text

Oxidative pentose phosphate pathway inhibition is a key determinant of antimalarial induced cancer cell death

E Salas, S Roy, T Marsh, B Rubin and J Debnath

Oncogene 2016 35: 2913-2922; advance online publication, October 5, 2015; 10.1038/onc.2015.348

Abstract | Full Text

Hedgehog/Patched-associated rhabdomyosarcoma formation from delta1-expressing mesodermal cells

F Nitzki, N Cuvelier, J Dräger, A Schneider, T Braun and H Hahn

Oncogene 2016 35: 2923-2931; advance online publication, September 21, 2015; 10.1038/onc.2015.346

Abstract | Full Text

LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells

N Yokdang, J Hatakeyama, J H Wald, C Simion, J D Tellez, D Z Chang, M M Swamynathan, M Chen, W J Murphy, K L Carraway III and C Sweeney

Oncogene 2016 35: 2932-2947; advance online publication, September 21, 2015; 10.1038/onc.2015.345

Abstract | Full Text

Corrigenda

Top

Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1

D Weekes, T G Kashima, C Zandueta, N Perurena, D P Thomas, A Sunters, C Vuillier, A Bozec, E El-Emir, I Miletich, A Patiño-Garcia, F Lecanda and A E Grigoriadis

Oncogene 2016 35: 2948; 10.1038/onc.2015.420

Full Text

The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development

A-L Joly, A Deepti, A Seignez, A Goloudina, S Hebrard, E Schmitt, S Richaud, E Fourmaux, A Hammann, A Collura, M Svrcek, G Jego, E Robinet, E Solary, O Demidov, E Kohli and C Garrido

Oncogene 2016 35: 2948; 10.1038/onc.2016.63

Full Text

Advertisement
Have you checked out the Oncogene top 10?

We have a continuously updated list of articles that highlight what has been downloaded by our website users over the past 7 days. Take a look as you may have missed out on something that could help with your research!

Click here to view the top 10
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: